Skip to main content

Closed

CTNM: Contineum Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

88thpctl

Volume

1.47×avg

Market Cap

579.11MUSD

P/E Ratio

-9.0TTM

Div Yield

-ann

Contineum Therapeutics, Inc.

CTNMNASDAQ·USD·Closed

Contineum Therapeutics, Inc.

CTNMNASDAQ·USD·Closed

$15.49

−1.65%

$15.49

−$0.26 (1.65%)

52W Range

88thpctl

Volume

1.47×avg

Mkt Cap

579.11MUSD

P/E

-9.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings